Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Pharmacol Biochem Behav. 2022 Aug 18;219:173450. doi: 10.1016/j.pbb.2022.173450

Table 1.

Effects of mGlu2 and mGlu3 receptors across brain circuits involved in mood disorders and alcohol use disorder

Brain Region Synaptic Plasticity
  Prelimbic Prefrontal Cortex ▪ mGlu2/3 agonism attenuates glutamate release and promotes LTD (31-43)
▪ mGlu2 regulates glutamate release (33-35,43)
▪ mGlu3 mediates postsynaptic LTD via AMPAR internalization (38-43)
  Hippocampus ▪ mGlu2/2 homodimers regulate glutamate release at mossy fiber (20)
▪ mGlu2/4 heterodimers regulate glutamate release in perforant path (46)
▪ mGlu3 activation promotes NMDAR-LTP (50, 51)
▪ Glial mGlu3 regulates adrenergic plasticity (54, 55)
  Striatum ▪ mGlu2 regulates glutamate and dopamine release (44, 58)
▪ mGlu2/3 agonism induces LTD in the nucleus accumbens (61)
  Amygdala ▪ mGlu2/3 agonism attenuates glutamate release and induces LTD in BLA (62), LA (63), CEA (64), and BNST (65)

Abbreviations: BLA, basolateral amygdala; BNST, bed nucleus of the stria terminalis; CEA, central nucleus of the amygdala; LA, lateral amygdala; LTD, long-term depression; LTP, long-term potentiation